This is particularly noteworthy because two competing oral small-molecule GLP-1 programs from Pfizer, lotiglipron (discontinued in 2023) and danuglipron (discontinued in April 2025), were terminated due to liver toxicity concerns
For example, Cignas Evernorth offers a cost cap insurance product for employer clients ( [69] )
These are not clinical arguments
After 72 weeks of treatment, participants taking tirzepatide lost 20.2% of their body weight (about 50.3 pounds), while those taking semaglutide lost 13.7% (about 33.1 pounds) of their body weight
Additionally, there are some compounded GLP-1 versions that contain vitamin B12 as an inactive ingredient, which isnt found in either of the commercially available drugs
Take RYBELSUS exactly as your healthcare provider tells you to Take 1 RYBELSUS tablet by mouth on an empty stomach in the morning with water (no more than 4 ounces)